As of 2025-05-30, the Fair Value of Inovio Pharmaceuticals Inc (INO) is -13.16 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.13 USD, the upside of Inovio Pharmaceuticals Inc is -717.61%.
With the market price of 2.13 USD and our fair value calculation, Inovio Pharmaceuticals Inc (INO) is not a good investment. Investing in INO stocks now will result in a potential loss of 717.61%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -166.41 | -303.66 | -279.82 | -135.12 | -107.25 | -198.45 |
| YoY growth | -39.42% | -82.48% | 7.85% | 51.71% | 20.62% | -8.34% |
| Market Cap (mil) | 78.11 |
| P/E | |
| Forward P/E |
| EPS | -2.63 |
| Avg earnings growth rate | -8.34% |
| TTM earnings | -96.48 |